A total of 25 drugs, including Bristol-Myers Squibb’s Baraclude, Dongwha’s Milican. and Chong Kun Dang’s Camtobell, are currently listed in the Green List, according to the data compiled by the Korea Food and Drug Administration.
The Green List is equivalent to the U.S. Food and Drug Administration’s Orange Book, the KFDA said.
For due registration of four different patents ahead of the c...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.